Compared with ipratropium alone, fluticasone/salmeterol combination therapy resulted in better clinical outcomes and similar or lower treatment costs in all COPD populations studied.
Manabu Akazawa, PhD
Advertisement
Articles by Manabu Akazawa, PhD
Advertisement
Latest Updated Articles
- Economic Assessment of Initial Maintenance Therapy for Chronic Obstructive Pulmonary Disease
Published: July 15th 2008 | Updated:
Advertisement
Advertisement
Trending on AJMC
1
Trump Announces Deals With Lilly, Novo to Cut Weight Loss Drug Prices
2
CMS Announces GENEROUS Model to Lower Medicaid Drug Prices
3
Medicare Advantage Reimbursement Structures Impact Home Health Delivery and Outcomes
4
Oncology Experts Spotlight Breakthrough Therapies, AI-Driven Care at PCOC 2025
5
